
Performing their functions as transporters of oxygen and carbon dioxide in the body, human erythrocytes constantly circulate and are exposed to the constant influence of various substances, including nutrients, drugs, medical devices covered with coatings, etc. Therefore, we aim to investigate the biophysical behavior of erythrocytes obtained from healthy volunteers to observe their morphological type changes, alterations in the zeta potential, the electrical conductivity of the erythrocytes in suspensions, and hemolysis in percentages during cells senescence, both in presence and in absence of natural polyelectrolytes pectin (PE) and chitosan (Chi) in form of multilayer films (PEM-films). Being constructed using the layer–by–layer technique, films are an object of interest of many researchers because of their high potential to be incorporated in biomedicine. By applying optical profilometry, electrophoretic light scattering, and spectrophotometry, we tested the polyelectrolytes for any potential harm on the erythrocytes. Based on our results and the one-way analysis of variance (ANOVA) statistical analysis, we reached the conclusion that the above-mentioned polyelectrolytes were harmlessness; therefore, PE and Chi are suitable substances to implement in the clinical practice in the form of drug delivery carriers and medical devices coatings, thereby directly contacting with the human blood.
Citation: Nikolay Kalaydzhiev, Elena Zlatareva, Dessislava Bogdanova, Svetozar Stoichev, Avgustina Danailova. Changes in biophysical properties and behavior of aging human erythrocytes treated with natural polyelectrolytes[J]. AIMS Biophysics, 2025, 12(1): 14-28. doi: 10.3934/biophy.2025002
[1] | Jiying Ma, Wei Lin . Dynamics of a stochastic COVID-19 epidemic model considering asymptomatic and isolated infected individuals. Mathematical Biosciences and Engineering, 2022, 19(5): 5169-5189. doi: 10.3934/mbe.2022242 |
[2] | Ahmed Alshehri, Saif Ullah . A numerical study of COVID-19 epidemic model with vaccination and diffusion. Mathematical Biosciences and Engineering, 2023, 20(3): 4643-4672. doi: 10.3934/mbe.2023215 |
[3] | Abdallah Alsammani, Calistus N. Ngonghala, Maia Martcheva . Impact of vaccination behavior on COVID-19 dynamics and economic outcomes. Mathematical Biosciences and Engineering, 2025, 22(9): 2300-2338. doi: 10.3934/mbe.2025084 |
[4] | Pannathon Kreabkhontho, Watchara Teparos, Thitiya Theparod . Potential for eliminating COVID-19 in Thailand through third-dose vaccination: A modeling approach. Mathematical Biosciences and Engineering, 2024, 21(8): 6807-6828. doi: 10.3934/mbe.2024298 |
[5] | Tianfang Hou, Guijie Lan, Sanling Yuan, Tonghua Zhang . Threshold dynamics of a stochastic SIHR epidemic model of COVID-19 with general population-size dependent contact rate. Mathematical Biosciences and Engineering, 2022, 19(4): 4217-4236. doi: 10.3934/mbe.2022195 |
[6] | Shina D. Oloniiju, Olumuyiwa Otegbeye, Absalom E. Ezugwu . Investigating the impact of vaccination and non-pharmaceutical measures in curbing COVID-19 spread: A South Africa perspective. Mathematical Biosciences and Engineering, 2022, 19(1): 1058-1077. doi: 10.3934/mbe.2022049 |
[7] | Anthony Morciglio, R. K. P. Zia, James M. Hyman, Yi Jiang . Understanding the oscillations of an epidemic due to vaccine hesitancy. Mathematical Biosciences and Engineering, 2024, 21(8): 6829-6846. doi: 10.3934/mbe.2024299 |
[8] | Fang Wang, Lianying Cao, Xiaoji Song . Mathematical modeling of mutated COVID-19 transmission with quarantine, isolation and vaccination. Mathematical Biosciences and Engineering, 2022, 19(8): 8035-8056. doi: 10.3934/mbe.2022376 |
[9] | Yujie Sheng, Jing-An Cui, Songbai Guo . The modeling and analysis of the COVID-19 pandemic with vaccination and isolation: a case study of Italy. Mathematical Biosciences and Engineering, 2023, 20(3): 5966-5992. doi: 10.3934/mbe.2023258 |
[10] | Tetsuro Kobayashi, Hiroshi Nishiura . Prioritizing COVID-19 vaccination. Part 2: Real-time comparison between single-dose and double-dose in Japan. Mathematical Biosciences and Engineering, 2022, 19(7): 7410-7424. doi: 10.3934/mbe.2022350 |
Performing their functions as transporters of oxygen and carbon dioxide in the body, human erythrocytes constantly circulate and are exposed to the constant influence of various substances, including nutrients, drugs, medical devices covered with coatings, etc. Therefore, we aim to investigate the biophysical behavior of erythrocytes obtained from healthy volunteers to observe their morphological type changes, alterations in the zeta potential, the electrical conductivity of the erythrocytes in suspensions, and hemolysis in percentages during cells senescence, both in presence and in absence of natural polyelectrolytes pectin (PE) and chitosan (Chi) in form of multilayer films (PEM-films). Being constructed using the layer–by–layer technique, films are an object of interest of many researchers because of their high potential to be incorporated in biomedicine. By applying optical profilometry, electrophoretic light scattering, and spectrophotometry, we tested the polyelectrolytes for any potential harm on the erythrocytes. Based on our results and the one-way analysis of variance (ANOVA) statistical analysis, we reached the conclusion that the above-mentioned polyelectrolytes were harmlessness; therefore, PE and Chi are suitable substances to implement in the clinical practice in the form of drug delivery carriers and medical devices coatings, thereby directly contacting with the human blood.
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus which can lead to severe sequelae or death due to breathing difficulties, headaches and loss of taste or smell [1,2]. Since the outbreak of COVID-19 in 2019, it has seriously affected the development of society and people's lives all over the world. In order to control COVID-19 as soon as possible, mathematical researchers have studied the infectious disease by establishing mathematical models for COVID-19 and analyzed their dynamical behavior[3,4,5,6,7,8].
The mathematical model of infectious disease was first proposed by Kermack and McKendrick[9]. They considered a fixed population with only three parts, i.e., SIR: the susceptible population S(t), the infected population I(t) and the recovery population R(t). Since then, many improved models, such as SEIR and SIRS models, have been used to describe various properties and laws of disease transmission[10,11,12,13,14,15]. Batabyal[16] built an SEIR model based on the seasonal transmission nature of the virus, analyzed the stability of the model and obtained the influence of the parameters on the basic regeneration number. Gumel et al.[17] proposed extended models of the infectious disease in which the stability of the equilibrium point and parameter estimation was studied. The global properties of an SIR model with nonlocal disperse and immigration effects were studied in [18]; they evaluated the persistence, extinction of the disease, global stability analysis of the model, existence of the positive equilibrium state and its uniqueness. The above deterministic models have well revealed the mechanism of infectious diseases. In fact, due to the disturbance of uncertain factors such as the environment, temperature, virus variation, prevention and control measures, the COVID-19 model with random factors has gradually attracted more and more attention[19,20,21,22,23]. Sweilam et al.[24] considered environmental noise and fractional calculus in the COVID-19 model which concluded that random factors have a considerable impact on the demise of infection. In a stochastic SIQ model affected by white noise, the sufficient conditions for stable distribution and disease extinction were proved by Din et al.[25]. Khan et al.[26] described a stochastic SEQIR model disturbed by white noise and telegraph noise at the same time; the uniqueness of global positive solutions and random thresholds was obtained. The stochastic coronavirus disease model with jump diffusion has also been researched, and Tesfay et al.[27] found that random disturbance can inhibit the outbreak of disease better than the deterministic model.
As we all know, vaccination can improve the level of immunity of the population and control the spread of the epidemic[28,29,30,31]. Djilali and Bentout[32] investigated an SVIR system with distributed delay and drew the conclusion that increasing the number of people vaccinated will reduce the spread of the disease. Zhang et al. [33] proposed a stochastic SVIR model based on one vaccination and got the sufficient conditions for the existence of non-trivial periodic solutions. A basic qualitative analysis of the positivity, invariant region and stability of disease-free equilibrium points was performed for a stochastic SVITR model with vaccination[34]. Wang et al.[35] constructed a stochastic COVID-19 mathematical model with quarantine, isolation and vaccination; they also studied the influence of vaccination rates, vaccine effectiveness and immune loss rates on COVID-19. Omar et al.[36] studied a discrete time-delayed influenza model with two strains and two vaccinations, and then concluded that the vaccination of one strain would affect the disease dynamics of the other strain. Alshaikh[37] generated a fractional order stochastic model based on the secondary vaccination and analyzed various vaccination strategies. With the development of current medical technology and research, more and more of the population has completed a secondary vaccination, even the third vaccination. Based on the above references, although there have been extensive studies and application of COVID-19, it should be pointed out that the complexity modeling of COVID-19 is still not enough, and that the mechanisms of transmission for the complex model are unclear. Based on this, the research on the transmission dynamics characteristics of stochastic COVID-19 epidemics with secondary vaccination is very necessary.
In this paper, a stochastic disease model with secondary vaccination is established in Section 2. In Section 3, we apply random Lyapunov function theory to study the qualitative characteristics. In the last section, numerical simulations are applied to verify the theoretical results.
In this study, we divided the population into seven time-dependent categories and built a mathematical model of COVID-19 with secondary vaccination (see Figure 1) based on the current situation of the epidemic. That is, it includes the susceptible person S(t), exposed person E(t), first vaccinator V1(t), second vaccinator V2(t), asymptomatic infected person A(t), symptomatic infected person I(t) and recovering person R(t).
In order to obtain the required results, we present the following assumptions:
1) The recovered population has immunity and will not be infected again.
2) Most people who receive the second vaccination will have immunity and will not be infected again.
3) Vaccinated people will transfer to exposure after being infected.
4) Assuming that the interval between two vaccinations is short, the first vaccinated person will not be infected temporarily.
The model is shown in Eq (2.1):
{dSdt=Λ−β1SA−β2SI−μ1S−ρ1S,dEdt=β1SA+β2SI+α2β2V2I−σE−μ1E,dV1dt=ρ1S−ρ2V1−μ1V1,dV2dt=ρ2V1−μ1V2−α2β2V2I−(1−α2)V2,dAdt=(1−ω)σE−αA−γ1A−(μ1+μ2)A,dIdt=ωσE+αA−γ2I−(μ1+μ2)I,dRdt=(1−α2)V2+γ1A+γ2I−μ1R, | (2.1) |
where Λ is the constant migration rate of the susceptible population, β1 is the transmission rate of asymptomatic infected persons, β2 is the transmission rate of symptomatic infected persons, ρ1 is the first vaccination rate, ρ2 is the second vaccination rate, σ is the infection rate of the exposed to the infected, ω is the proportion of infections in symptomatic patients, α is the ratio of asymptomatic infected people to symptomatic infected people and α2 (0<α2<1) is the ratio of secondary vaccinators to symptomatic infected people, so 1−α2 is the effectiveness of the vaccine. γ1 and γ2 respectively represent the recovery rate of asymptomatic and symptomatic infected persons. μ1 and μ2 represent the natural mortality rate and disease-related mortality rate respectively. All parameters are positive.
The disease-free equilibrium point of Eq (2.1) can be obtained (E,A and I are all zero)
P0=(S∗,0,V∗1,V∗2,0,0,R∗), |
where
S∗=Λμ1+ρ1,V∗1=Λρ1(μ1+ρ1)(μ1+ρ2),V∗2=Λρ1ρ2(μ1+ρ1)(μ1+ρ2)(μ1+1−α2),R∗=Λρ1ρ2(1−α2)μ1(μ1+ρ1)(μ1+ρ2)(μ1+1−α2). |
Using the next generation matrix method[17], the basic regeneration number of Eq (2.1) is
R0=[Λβ1μ1+ρ1+Λα2β2ρ1ρ2(μ1+ρ1)(μ1+ρ2)(μ1+1−α2)](α+ωσ(γ1+μ1+μ2)(σ+μ1)(α+γ1+μ1+μ2)(γ2+μ1+μ2))−(1−ω)σ(σ+μ1)(α+γ1+μ1+μ2). |
As we all know, the following theoretical results on equilibrium stability have been established[1]:
1) when R0<1, the disease-free equilibrium point of the infectious disease model is locally asymptotically stable; otherwise, it is unstable;
2) when R0=1, the infectious model passes through a transcritical bifurcation near the disease-free equilibrium.
In fact, in order to have a more accurate understanding of the real disease development process, we added the influence of random factors into Eq (2.1). The improved stochastic model SEV1V2AIR is as follows:
{dS=[Λ−β1SA−β2SI−(μ1+ρ1)S]dt+σ1dB1(t),dE=[β1SA+β2SI+α2β2V2I−(σ+μ1)E]dt+σ2dB2(t),dV1=[ρ1S−(ρ2+μ1)V1]dt+σ3dB3(t),dV2=[ρ2V1−μ1V2−α2β2V2I−(1−α2)V2]dt+σ4dB4(t),dA=[(1−ω)σE−(α+γ1+μ1+μ2)A]dt+σ5dB5(t),dI=[ωσE+αA−(γ2+μ1+μ2)I]dt+σ6dB6(t),dR=[(1−α2)V2+γ1A+γ2I−μ1R]dt+σ7dB7(t), | (2.2) |
where Bi(t),i=1,2,3,⋯,7 is the independent standard Brownian motion which represents small disturbance on each variable, and σi≥0 is the intensity of Bi(t),i=1,2,3,⋯,7.
In order to study the dynamical behavior of the infectious disease model proposed in this paper, we first need to consider whether the solution is global and non-negative. So in this section, we will prove that there exists a unique global positive solution for Eq (2.2).
Theorem 1. For any given initial value {S(0),E(0),V1(0),V2(0),A(0),I(0),R(0)}∈R7+, Eq (2.2) has a unique positive solution {S(t),E(t),V1(t),V2(t),A(t),I(t),R(t)} at t≥0, and this solution will stay in R7+ with a probability of 1. So, for all t≥0, the solution {S(t),E(t),V1(t),V2(t),A(t),I(t),R(t)}∈R7+ a.s.
Proof: Since the coefficients of the equation are Lipschitz continuous, for any given initial value {S(0),E(0),V1(0),V2(0),A(0),I(0),R(0)}∈R7+, there is a unique local solution {S(t),E(t),V1(t),V2(t),A(t),I(t),R(t)},t∈[0,τe), where τe stands for the explosion time, and if τe=∞, this local solution is global. To do that, we have to make k0 sufficiently large and S(t), E(t), V1(t), V2(t), A(t), I(t), R(t) is in the interval [1k0,k0]. For each integer k≥k0, we define the stopping time as follows:
τk=inf{t∈[0,τe):S(t)∉(1k,k)orE(t)∉(1k,k)orV1(t)∉(1k,k)=orV2(t)∉(1k,k)orA(t)∉(1k,k)orI(t)∉(1k,k)orR(t)∉(1k,k)}. |
In this section, we set inf∅=∞ (∅ denotes the empty set). It is easy to get τk that is increasing as k→∞. Set τ∞=limk→∞τk which implies τ∞<τk a.s.. If the hypothesis τ∞<∞ is true, then τe=∞ a.s. For all t≥0, this means
{S(t),E(t),V1(t),V2(t),A(t),I(t),R(t)}∈R7+ a.s. |
In other words, we just prove τe=∞ a.s. If this statement is wrong, then there are constants T>0 and ε∈(0,1) which make P{τ∞<T}>ε. Hence there is an integer k1>k0 such that
P{τ∞≤T}≥ε, ∀k>k1. | (3.1) |
Define a C2−function V:R7+→R+ as follows:
V(S,E,V1,V2,A,I,R)=(S−1−lnS)+(E−1−lnE)+(V1−1−lnV1)+(V2−1−lnV2)+(A−1−lnA)+(I−1−lnI)+(R−1−lnR); | (3.2) |
the non-negativity of Eq (3.2) can be obtained from
u−1−lnu≥0, ∀u>0. |
Using Itˆos formula, we can get
dV(S,E,V1,V2,A,I,R)=LV(S,E,V1,V2,A,I,R)dt+σ1(S−1)dB1(t)+σ2(E−1)dB2(t)+σ3(V1−1)dB3(t)+σ4(V2−1)dB4(t)+σ5(A−1)dB5(t)+σ6(I−1)dB6(t)+σ7(R−1)dB7(t), | (3.3) |
where LV:R7+→R+ is defined by
LV(S,E,V1,V2,A,I,R)=(1−1S)[Λ−β1SA−β2SI−(μ1+ρ1)S]+(1−1E)[β1SA+β2SI+α2β2V2I−(σ+μ1)E]+(1−1V1)[ρ1S−(ρ2+μ1)V1]+(1−1V2)[ρ2V1−μ1V2−α2β2V2I−(1−α2)V2]+(1−1A)[(1−ω)σE−(α+γ1+μ1+μ2)A]+(1−1I)[ωσE+αA−(γ2+μ1+μ2)I]+(1−1R)[(1−α2)V2+γ1A+γ2I−μR]+12(σ21+σ22+σ23+σ24+σ25+σ26+σ27)⩽Λ+ρ1+σ+ρ2+(1−α2)+α+γ1+γ2+2μ2+7μ1+(β2(1−α2)−μ1)I+(β1−μ1)A−μ2(A+I)−μ1(S+E+V1+V2+A+I+R)+12(σ21+σ22+σ23+σ24+σ25+σ26+σ27)⩽Λ+σ+ρ1+ρ2+(1−α2)+α+γ1+γ2+2μ1+7μ2+12(σ21+σ22+σ23+σ24+σ25+σ26+σ27)=:K, |
where β2≤max{μ11−α2,μ1} is assumed and K(K∈N+) is a positive constant, which does not rely on S, E, V1, V2, A, I, R and t. So, there is
dV(S,E,V1,V2,A,I,R)⩽Kdt+σ1(S−1)dB1(t)+σ2(E−1)dB2(t)+σ3(V1−1)dB3(t)+σ4(V2−1)dB4(t)+σ5(A−1)dB5(t)+σ6(I−1)dB6(t)+σ7(R−1)dB7(t). | (3.4) |
Let us integrate both sides of Eq (3.4) from 0 to τk∧T=min{τk,T} and then take the expectation; we can get
EV(S(τk∧T),E(τk∧T),V1(τk∧T),V2(τk∧T),A(τk∧T),I(τk∧T),R(τk∧T))⩽V(S(0),E(0),V1(0),V2(0),A(0),I(0),R(0))+KE(τk∧T)⩽V(S(0),E(0),V1(0),V2(0),A(0),I(0),R(0))+KT. | (3.5) |
Set Ωk={τk≤T}, and we obtain P{Ωk}≥ε by Eq (3.1). Now, notice that, for every ω∈Ωk, there is at least one of S(τk,ω), E(τk,ω), V1(τk,ω), V2(τk,ω), A(τk,ω), I(τk,ω) or R(τk,ω) that equals to k or 1k.
Therefore
V{S(τk,ω),E(τk,ω),V1(τk,ω),V2(τk,ω),A(τk,ω),I(τk,ω),R(τk,ω)} |
is no less than
k−1−lnk or 1k−1+lnk; |
thus,
V{S(τk,ω),E(τk,ω),V1(τk,ω),V2(τk,ω),A(τk,ω),I(τk,ω),R(τk,ω)}≥min{k−1−lnk,1k−1+lnk}. | (3.6) |
Substitute Eq (3.5) into Eq (3.6), we have
V(S(0),E(0),V1(0),V2(0),A(0),I(0),R(0))+KT⩾E[1Ωkω∀V{S(τk,ω),E(τk,ω),V(τk,ω),V(τk,ω),A(τk,ω),I(τk,ω),R(τk,ω)}]⩾εmin{k−1−lnk,1k−1+lnk}, | (3.7) |
where 1Ωkω denotes the indicator function of Ωk. Letting k→∞, then
∞>V(S(0),E(0),V1(0),V2(0),A(0),I(0),R(0))+KT=∞. | (3.8) |
Equation (3.8) is a contradiction. Therefore we have τ∞=∞. The proof is completed. Therefore, there exists a unique global positive solution to Eq (2.2).
Lemma 1. For any initial value
{S(0),E(0),V1(0),V2(0),A(0),I(0),R(0)}∈R7+, |
Eq (2.2) always has a unique positive solution
{S(t),E(t),V1(t),V2(t),A(t),I(t),R(t)}∈R7+att≥0, |
{S(t),E(t),V1(t),V2(t),A(t),I(t),R(t)} has the following properties:
limt→∞S(t)t=0,limt→∞E(t)t=0,limt→∞V1(t)t=0,limt→∞V2(t)t=0,limt→∞A(t)t=0,limt→∞I(t)t=0,limt→∞R(t)t=0, | (4.1) |
and
limt→∞logS(t)t⩽0,limt→∞logE(t)t⩽0,limt→∞logV1(t)t⩽0,limt→∞logV2(t)t⩽0,limt→∞logA(t)t⩽0,limt→∞logI(t)t⩽0,limt→∞logR(t)t⩽0, | (4.2) |
as well as
limt→∞∫t0S(x)dB1(x)t=0,limt→∞∫t0E(x)dB2(x)t=0,limt→∞∫t0V1(x)dB3(x)t=0,limt→∞∫t0V2(x)dB4(x)t=0,limt→∞∫t0A(x)dB5(x)t=0,limt→∞∫t0I(x)dB6(x)t=0,limt→∞∫t0R(x)dB7(x)t=0. | (4.3) |
In order to get the conditions of disease extinction, we set Theorem 2.
Theorem 2. Let {S(t),E(t),V1(t),V2(t),A(t),I(t),R(t)}∈R7+ be a positive solution for Eq (2.2), and the initial solution of Eq (2.2) is {S(0),E(0),V1(0),V2(0),A(0),I(0),R(0)}.
If RS0=(1−ω)σΛμ1(α+γ1+μ1+μ2+σ252)<1, then the solution of the system has the following properties:
limt→∞suplogA(t)t<0,limt→∞suplogI(t)t<0. | (4.4) |
Proof: First, integrate Eq (2.2) to obtain
S(t)−S(0)t=Λ−β2⟨S(t)⟩⟨I(t)⟩−β1⟨S(t)⟩⟨A(t)⟩−(μ1+ρ1)⟨S(t)⟩+σ1t∫t0SdB1(x),E(t)−E(0)t=β2⟨S(t)⟩⟨I(t)⟩+β1⟨S(t)⟩⟨A(t)⟩+α2β2⟨V2(t)⟩⟨I(t)⟩−(μ1+σ)⟨E(t)⟩+σ2t∫t0EdB2(x),V1(t)−V1(0)t=ρ1⟨S(t)⟩−(μ1+ρ2)⟨V1(t)⟩+σ3t∫t0V1dB3(x),V2(t)−V2(0)t=ρ2⟨V1(t)⟩−μ1⟨V2(t)⟩−α2β2⟨V2(t)⟩⟨I(t)⟩−(1−α2)⟨V2(t)⟩+σ4t∫t0V2dB4(x),A(t)−A(0)t=(1−ω)σ⟨E(t)⟩−(α+γ1)⟨A(t)⟩−(μ1+μ2)⟨A(t)⟩+σ5t∫t0AdB5(x), | (4.5) |
I(t)−I(0)t=ωσ⟨E(t)⟩+α⟨A(t)⟩−γ2⟨I((t)⟩−(μ1+μ2)⟨I(t)⟩+σ6t∫t0IdB6(x),R(t)−R(0)t=(1−α2)⟨V2(t)⟩+γ1⟨A(t)⟩+γ2⟨I(t)⟩−μ1⟨R(t)⟩+σ7t∫t0RdB7(x). |
Adding the left and right sides of Eq (4.5) respectively, we obtain
S(t)−S(0)t+E(t)−E(0)t+V1(t)−V1(0)t+V2(t)−V2(0)t+A(t)−A(0)t+I(t)−I(0)t+R(t)−R(0)t=A−μ1[⟨S(t)⟩+⟨E(t)⟩+⟨V(t)⟩+⟨V(t)⟩+⟨R(t)⟩]−(μ1+μ2)[⟨A(t)⟩+⟨I(t)⟩]+σ1t∫t0SdB1(x)+σ2t∫t0EdB2(x)+σ3t∫t0V1dB3(x)+σ4t∫t0V2dB4(x)+σ5t∫t0AdB5(x)+σ6t∫t0IdB6(x)+σ7t∫t0RdB7(x). |
At this time, we have
⟨S(t)⟩=Aμ1−[⟨E(t)⟩+⟨V1(t)⟩+⟨V2(t)⟩+⟨R(t)⟩]−(μ1+μ2)μ1[⟨A(t)⟩+⟨I(t)⟩]+ϕ(t), | (4.6) |
where
ϕ(t)=σ1μ1t∫t0SdB1(x)+σ2μ1t∫t0EdB2(x)+σ3μ1t∫t0V1dB3(x)+σ4μ1t∫t0V2dB4(x)+σ5μ1t∫t0AdB5(x)+σ6μ1t∫t0IdB6(x)+σ7μ1t∫t0RdB7(x)−1μ1[S(t)−S(0)t+E(t)−E(0)t+V1(t)−V1(0)t+V2(t)−V2(0)t]−1μ1[A(t)−A(0)t+I(t)−I(0)t+R(t)−R(0)t]. |
We can also obtained
⟨E(t)⟩=Aμ1−[⟨S(t)⟩+⟨V1(t)⟩+⟨V2(t)⟩+⟨R(t)⟩]−(μ1+μ2)μ1[⟨A(t)⟩+⟨I(t)⟩]+ϕ(t). | (4.7) |
Then, Itˆos formula is used for the fifth formula in Eq (2.2), we can get
dlogA(t)=[(1−ω)σE−(α+γ1+μ1+μ2)A]1Adt−σ252dt+σ5dB5(t). | (4.8) |
Integrate Eq (4.8) from 0 to t:
logA(t)−logA(0)⩽∫t0[(1−ω)σE−(α+γ1+μ1+μ2+σ252)]dt+σ5dB5(t)⩽[(1−ω)σE−(α+γ1+μ1+μ2+σ252)]t+σ5B5(t). | (4.9) |
Substitute Eq (4.7) into Eq (4.9) and divide by t, so there is
logA(t)−logA(0)t⩽(1−ω)σ⟨E(t)⟩−(α+γ1+μ1+μ2+σ252)+σ5B5(t)t⩽(1−ω)σμ1Λ−(μ1+μ2)(1−ω)σμ1⟨A(t)⟩+(1−ω)σϕ(t)−(α+γ1+μ1+μ2+σ252)+σ5B5(t)t⩽(α+γ1+μ1+μ2+σ252)((1−ω)σAμ1(α+γ1+μ1+μ2+σ252)−1)−(μ1+μ2)(1−ω)σμ1⟨A(t)⟩+σ5B5(t)t+φ(t), | (4.10) |
where φ(t)=σ(1−ω)ϕ(t). Rs0 is the called random threshold and it is shown as
Rs0=(1−ω)σAμ1(α+γ1+μ1+μ2+σ252). |
According to the strong number theorem, we have limt→∞B5(t)t=0, i.e., limt→∞σ5B5(t)t=0. Therefore, take the limit on both sides of Eq (4.10) at the same time; we then get
limt→∞suplogA(t)t⩽(α+γ1+μ1+μ2+σ252)(Rs0−1)−(μ1+μ2)(1−ω)σμ1⟨A(t)⟩<0; |
this means that when Rs0<1
limt→∞A(t)=0. | (4.11) |
Taking the limit on both sides of Eq (4.6) at the same time, we can obtain
limt→∞S(t)=Λμ1. | (4.12) |
Set M={ω=Ω:limt→∞S(t)=Λμ1}, which means that P(M)=1 at this point.
From Eq (4.7), we can get
limt→∞⟨E(t)⟩⩽Λμ1. |
For ∀ω∈M,t>0, we can get limt→∞E(ω,t)=0, ω∈M. Considering that P(M)=1, we can obtain
limt→∞E(t)=0,a.s.. | (4.13) |
It can be seen from Eq (4.5) that
I(t)−I(0)t=ωσ⟨E(t)⟩+α⟨A(t)⟩−γ2⟨I((t)⟩−(μ1+μ2)⟨I(t)⟩+σ6t∫t0IdB6(x), |
i.e.
⟨I(t)⟩=1γ2+μ1+μ2[ωσ⟨E(t)⟩+α⟨A(t)⟩−I(t)−I(0)t+σ6t∫t0IdB5(t)]. | (4.14) |
It can be concluded that limt→∞⟨I(t)⟩=0, a.s.
Therefore, this conclusion is proved.
In this section, in order to verify the effects of vaccination and random disturbance on controlling the spread of disease, we used the Milstein method[38,39] to conduct numerical simulations of the stochastic model described by Eq (2.2).
The parameter values of Eq (2.2) are shown in the following table (Table 1).
Parameter | Value | Source |
Λ | 0.03 | |
β1 | 1.038 | |
β2 | 0.083 | |
σ | 15.2 | [40] |
ω | 0.8 | [40] |
α | 0.19 | [40] |
γ1 | 0.3 | [41] |
γ2 | 0.001 | [41] |
μ1 | 0.09 | [41] |
μ2 | 0.001 | [41] |
Eq (2.2) is discretized into the following format:
{Sj=Sj−1+[Λ−(β1Aj−1+β2Ij−1)Sj−1−(μ1+ρ1)Sj−1]Δt+σ1(Sj−1)√Δtζj−1+σ212(Sj−1)(ζ2j−1−1)Δt,Ej=Ej−1+[(β1Aj−1+β2Ij−1)Sj−1+α2β2V2j−1Ij−1−(σ+μ1)Ej−1]Δt+σ2(Ej−1)√Δtζj−1+σ222(Ej−1)(ζ2j−1−1)Δt,V1j=V1j−1+[ρ1Sj−1−(ρ2+μ1)V1j−1]Δt+σ3(V1j−1)√Δtζj−1+σ232(V1j−1)(ζ2j−1−1)Δt,V2j=V2j−1+[ρ2V1j−1−α2β2V2j−1Ij−1−(μ1+1−α2)V2j−1]Δt+σ4(V2j−1)√Δtζj−1+σ242(V2j−1)(ζ2j−1−1)Δt,Aj=Aj−1+[(1−ω)σEj−1−(α+γ1+μ1+μ2)Aj−1]Δt+σ5(Aj−1)√Δtζj−1+σ252(Aj−1)(ζ2j−1−1)Δt,Ij=Ij−1+[ωσEj−1+αAj−1−(γ2+μ1+μ2)Ij−1]Δt+σ6(Ij−1)√Δtζj−1+σ262(Ij−1)(ζ2j−1−1)Δt,Rj=Rj−1+[(1−α2)V2j−1+γ1Aj−1+γ2Ij−1−μ1Rj−1]Δt+σ7(Rj−1)√Δtζj−1+σ272(Rj−1)(ζ2j−1−1)Δt, |
where ζj(j=1,2,⋯,n) are independent Gaussian random variables N(0,1). Based on the parameters in Table 1, the initial value of the numerical experiment was set as (S(0),E(0),V1(0),V2(0),A(0),I(0),R(0))=(0.1,0.1,0,0,0.1,0.2,0).
Based on Table 1, let ρ1=0.9,ρ2=0.9,α2=0.008, σ1=0.15, σ2=0.063, σ3=0.338, σ4=0.068, σ5=0.25, σ6=0.09 and σ7=0.023. The asymptotic behavior of the stochastic model at the disease-free equilibrium point E0=(0.0303,0,0.0275,0.0229,0,0,0.2526) can be shown in Figure 2. At this time, the random threshold is Rs0=0.0209<R0=0.2872<1.
In Figure 2, asymptomatic and symptomatic infections gradually decrease until they disappear, which means that the disease tends to extinction. This is consistent with the previous theoretical results on the extinction of disease. In other words, appropriate noise intensity can promote the extinction of the disease. With the passage of time, the probability of disease extinction becomes 1.
Based on the parameters given in Table 1, ρ1=0.9,α2=0.008 and we let ρ2 equal to 0, 0.5 and 0.9 respectively, the extinction trends of asymptomatic infected person A and symptomatic infected person I are shown in Figure 3(a) and (b). It is clear from Figure 3 that with the increase of the secondary vaccination rate, disease extinction approaches faster. In addition, when ρ1=0.9,ρ2=0.9, the extinction trends of the two infected populations are shown in Figure 3(c) and (d) as α2 is equal to 0.008, 0.025 and 0.05 respectively. We found that the smaller the value of α2 and the higher the vaccine efficiency, the faster the disease tends to extinction. So, we can know from Figure 3 that improving the secondary vaccination rate and vaccine efficiency is one of the important measures to effectively control the epidemic.
According to Theorem 2, σ5 is random intensity acting on asymptomatic infected persons which can directly affect the random threshold Rs0. This means that σ5 can directly affect the speed of the extinction of the disease and that other noise intensity types indirectly affects the extinction of the disease. Therefore the influence of σ5 on the extinction of the disease was mainly investigated. When other noise intensity types are kept constant and σ5 is set to 0, 0.05, 0.15 and 0.25 respectively, the influence of different noise intensities on disease extinction is shown in Figure 4. It can be seen in Figure 4 that the noise intensity can promote the extinction of the infected population. Under the constraint of a random threshold, the higher the noise intensity σ5, the faster the disease-free equilibrium point is reached.
In real life, σ5 represents the disturbance intensity of infected persons under the policies of isolation measures, the effective diagnosis of asymptomatic infected persons and self-protection. From the above analysis, it can be seen that the more complete the intervention policies for infected people, the better the disease prevention and control.
At present, the mathematical modeling of infectious diseases plays an important role in providing epidemic prevention and control strategies. In order to control the epidemic in real life, quarantine and other epidemic prevention measures have been proposed, which have become a random disturbance factor affecting the spread of the epidemic in the infectious disease model. So far, vaccination is considered to be one of the most popular and effective methods to alleviate and prevent epidemics. Based on this, the SEV1V2AIR model was established by considering random disturbance and secondary vaccination, and then the dynamical analysis of the model was carried out. First, using the stop time theory and Lyapunov analysis method, it was proved that the proposed model has a globally unique positive solution. Then, we obtained the theoretical results about the random threshold Rs0. When RS0<1, the disease tends to become extinct. Finally, numerical simulations were performed to verify the theoretical results.
In this paper, the theoretical and numerical simulations show that vaccination and random disturbance have a great impact on disease dynamics. The intensity of the random disturbance directly affects the extinction rate of the infected population. In addition, the higher the secondary vaccination rate and vaccine effectiveness, the faster the extinction rate of the disease. In order to control infectious diseases, we can not only reduce the disease transmission rate through isolation, self-protection and other measures, but also encourage susceptible individuals to get vaccinated and improve the effectiveness of the vaccine. These conclusions provide theoretical basis for preventing and controlling the spread of COVID-19.
Furthmore, the impact of some discontinuous factors and vaccine frequency on COVID-19 will be discussed in the future work because of more influential disturbances, such as large-scale human aggregation, the promotion of antiviral drugs and so on.
This work was supported by grants from the National Natural Science Foundation of China (No. 11772002), Ningxia higher education first-class discipline construction funding project (NXYLXK2017B09), Major special project of North Minzu University (No. ZDZX201902), Open project of The Key Laboratory of Intelligent Information and Big Data Processing of NingXia Province (No. 2019KLBD008) and Postgraduate innovation project of North Minzu University (YCX22099). The authors would like to thank the editors and reviewers for their valuable suggestions on the logic and preciseness of this article.
The authors declare that there is no conflict of interest.
[1] |
Kuck L, Peart JN, Simmonds MJ (2020) Active modulation of human erythrocyte mechanics. Am J Physiol Cell Physiol 319: C250-C257. https://doi.org/10.1152/ajpcell.00210.2020 ![]() |
[2] |
Sakamoto W, Azegami N, Konuma T, et al. (2021) Single-cell native mass spectrometry of human erythrocytes. J Anal Chem 93: 6583-6588. https://doi.org/10.1021/acs.analchem.1c00588 ![]() |
[3] |
Giardina B, Messana I, Scatena R, et al. (1995) The multiple functions of hemoglobin. J Crit Rev Biochem Mol Biol 30: 165-196. https://doi.org/10.3109/10409239509085142 ![]() |
[4] |
Thiagarajan P, Parker CJ, Prchal JT (2021) How do red blood cells die?. J Front Physiol 12: 655393. https://doi.org/10.3389/fphys.2021.655393 ![]() |
[5] |
Dinarelli S, Longo G, Dietler G, et al. (2018) Erythrocyte's aging in microgravity highlights how environmental stimuli shape metabolism and morphology. Sci Rep-UK 8: 5277. https://doi.org/10.1038/s41598-018-22870-0 ![]() |
[6] |
Goodman SR, Hughes KMH, Kakhniashvili DG, et al. (2007) The isolation of reticulocyte-free human red blood cells. J Exp Biol Med (Maywood) 232: 1470. https://doi.org/10.3181/0706-RM-163 ![]() |
[7] |
Pretini V, Koenen MH, Kaestner L, et al. (2019) Red blood cells: chasing interactions. Front Physiol 10: 945. https://doi.org/10.3389/fphys.2019.00945 ![]() |
[8] |
Grebowski J, Kazmierska-Grebowska P, Cichon N, et al. (2022) The effect of fullerenol C60(OH)36 on the antioxidant defense system in erythrocytes. Int J Mol Sci 23: 119. https://doi.org/10.3390/ijms23010119 ![]() |
[9] |
Lawrence C, Meier E (2021) Chapter 17-erythrocyte disorders. Biochemical and Molecular Basis of Pediatric Disease : 529-560. https://doi.org/10.1016/B978-0-12-817962-8.00023-8 ![]() |
[10] |
Maheshwari N, Khan FH, Mahmood R (2019) Pentachlorophenol-induced cytotoxicity in human erythrocytes: enhanced generation of ROS and RNS, lowered antioxidant power, inhibition of glucose metabolism, and morphological changes. Environ Sci Pollut Res 13: 12985-13001. https://doi.org/10.1007/s11356-019-04736-8 ![]() |
[11] |
Piscopo M, Notariale R, Tortora F, et al. (2020) Novel insights into mercury efects on hemoglobin and membrane proteins in human erythrocytes. Molecules 25: 3278. https://doi.org/10.3390/molecules25143278 ![]() |
[12] | Berzuini A, Bianco C, Migliorini AC, et al. (2021) Red blood cell morphology in patients with COVID-19-related anaemia. J Blood Transfus 19: 34-36. https://doi.org/10.2450/2020.0242-20 |
[13] | Yamaguchi T, Ishimatu T (2020) Effects of cholesterol on membrane stability of human erythrocytes. J Biol Pharm Bull 43: 604-1608. https://doi.org/10.1248/bpb.b20-00435 |
[14] |
Jan KM, Chien SH (1973) Role of surface electric charge in red blood cell interactions. J Gen Physiol 61: 638-654. https://doi.org/10.1085/jgp.61.5.638 ![]() |
[15] |
Vincy A, Mazumder S, Amrita Banerjee I, et al. (2022) Recent progress in red blood cells-derived particles as novel bioinspired drug delivery systems: challenges and strategies for clinical translation. Front Chem 10: 905256. https://doi.org/10.3389/fchem.2022.905256 ![]() |
[16] |
Tokumasu F, Ostera GR, Amaratunga Ch, et al. (2012) Modifications in erythrocyte membrane zeta potential by plasmodium falciparum Infection. Exp Parasitol 131: 245-251. https://doi.org/10.1016/j.exppara.2012.03.005 ![]() |
[17] | Selim NS (2010) Comparative study on the effect of radiation on whole blood and isolated red blood cells. Romanian J Biophys 20: 127-136. |
[18] |
Chen XY, Huang YX, Liu W, et al. (2007) Membrane surface charge and morphological and mechanical properties of young and old erythrocytes. J Curr Appl Phys 7: 94-96. https://doi.org/10.1016/j.cap.2006.11.024 ![]() |
[19] |
Kuchinka J, Willems Ch, Telyshev DV, Groth T (2021) Control of blood coagulation by hemocompatible material surfaces—a review. Bioengineering 8: 215. https://doi.org/10.3390/bioengineering8120215 ![]() |
[20] |
Doltchinkova V, Stoylov S, Angelova P (2021) Viper toxins affect membrane characteristics of human erythrocytes. Biophys Chem 270: 106532. https://doi.org/10.1016/j.bpc.2020.106532 ![]() |
[21] |
Qian J, Chen Y, Wang Q, et al. (2021) Preparation and antimicrobial activity of pectin-chitosan embedding nisin microcapsules. Eur Polym J 157: 110676. https://doi.org/10.1016/j.eurpolymj.2021.110676 ![]() |
[22] |
Xie Q, Zheng X, Li L, et al. (2021) Effect of curcumin addition on the properties of biodegradable pectin/chitosan films. Molecules 26: 2152. https://doi.org/10.3390/molecules26082152 ![]() |
[23] |
Jovanović J, Ćirković J, Radojković A, et al. (2021) Chitosan and pectin-based films and coatings with active components for application in antimicrobial food packaging. Prog Org Coat 158: 106349. https://doi.org/10.1016/j.porgcoat.2021.106349 ![]() |
[24] |
Jiang Z, Zhao S, Yang M, et al. (2022) Structurally stable sustained-release microcapsules stabilized by self-assembly of pectin-chitosan-collagen in aqueous two-phase system. J Food Hydrocolloids 125: 107413. https://doi.org/10.1016/j.foodhyd.2021.107413 ![]() |
[25] |
Mallory A, Giannopoulos S, Lee P, et al. (2021) Covered stents for endovascular treatment of aortoiliac occlusive disease: a systematic review and meta-analysis. Vasc Endovasc Surg 55: 560-570. https://doi.org/10.1177/15385744211010381 ![]() |
[26] | Kawagoe Y, Otuka F, Onozuka D, et al. (2022) Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathologic study. EuroIntervention 18: 1284-1294. https://doi.org/10.4244/EIJ-D-22-00650 |
[27] |
McKenna CG, Vaughan TJ (2022) A computational framework examining the mechanical behaviour of bare and polymer-covered self-expanding laser-cut stents. J Cardiovasc Eng Tech 13: 466-480. https://doi.org/10.1007/s13239-021-00597-w ![]() |
[28] |
Hu B, Guo Y, Li H, et al. (2021) Recent advances in chitosan-based layer-by-layer biomaterials and their biomedical applications. Carbohyd Polym 271: 118427. https://doi.org/10.1016/j.carbpol.2021.118427 ![]() |
[29] |
Arnon-Ripsb H, Poverenova E (2018) Improving food products' quality and storability by using layer by layer edible coatings. Trends Food Sci Tech 75: 81-92. https://doi.org/10.1016/j.tifs.2018.3.003 ![]() |
[30] |
Grebowski J, Konarska A, Piotrowski P, et al. (2024) Kinetics of metallofullerenol reactions with the products of water radiolysis: implications for radiotherapeutics. ACS Appl Nano Mater 7: 539-549. https://doi.org/10.1021/acsanm.3c04747 ![]() |
[31] |
Silva DCN, Jovino CN, Silva CAL, et al. (2012) Optical tweezers as a new biomedical tool to measure zeta potential of stored red blood cells. Plos One 7: e31778. https://doi.org/10.1371/journal.pone.0031778 ![]() |
[32] |
Raat NJ, Verhoeven AJ, Mik EG (2005) The effect of storage time of human red cells on intestinal microcirculatory oxygenation in a rat isovolemic exchange model. Crit Care Med 33: 39-45. https://doi.org/10.1097/01.ccm.0000150655.75519.02 ![]() |
[33] |
Chen KY, Lin TH, Yang CY, et al. (2018) Mechanics for the adhesion and aggregation of red blood cells on chitosan. J Mechanics 34: 725-732. https://doi.org/10.1017/jmech.2018.27 ![]() |
[34] |
Kou S, Peters L, Mucalo M (2022) Chitosan: a review of molecular structure, bioactivities and interactions with the human body and microorganisms. J Carbohyd Polym 282: 119132. https://doi.org/10.1016/j.carbpol.2022.119132 ![]() |
[35] |
Nadesh R, Narayanan D, Sreerekha PR, et al. (2013) Hematotoxicological analysis of surface-modified and unmodified chitosan nanoparticles. J Biomed Mater Res Part A 101A: 2957-2966. https://doi.org/10.1002/jbm.a.34591 ![]() |
[36] |
Balan V, Verestiuc L (2014) Strategies to improve chitosan hemocompatibility: a review. Eur Polym J 53: 171-188. https://doi.org/10.1016/j.eurpolymj.2014.01.033 ![]() |
[37] |
Zhou X, Zhang X, Zhou J, et al. (2017) An investigation of chitosan and its derivatives on red blood cell agglutination. RSC Adv 7: 12247-12254. https://doi.org/10.1039/C6RA27417 ![]() |
[38] |
Wang W, Xue Ch, Mao X (2020) Chitosan: structural modification, biological activity and application. Int J Biol Macromol 164: 4532-4546. https://doi.org/10.1016/j.ijbiomac.2020.09.042 ![]() |
[39] |
Azmana M, Mahmood S, Hilles AR, et al. (2021) A review on chitosan and chitosan-based bionanocomposites: Promising material for combatting global issues and its applications. Int J Biol Macromol 185: 832-848. https://doi.org/10.1016/j.ijbiomac.2021.07.023 ![]() |
[40] |
Negm NA, Hefni HHH, Abd-Elaal AAA, et al. (2020) Advancement on modification of chitosan biopolymer and its potential applications. Int J Biol Macromol 152: 681-702. https://doi.org/10.1016/j.ijbiomac.2020.02.196 ![]() |
[41] |
Erdogan E, Bajaj R, Lansky A, et al. (2022) Intravascular imaging for guiding in-stent restenosis and stent thrombosis therapy. J Am Heart Assoc 11: e026492. https://doi.org/10.1161/JAHA.122.026492 ![]() |
[42] |
Nagaraja V, Schwarz K, Moss S, et al. (2020) Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: a systematic review and pooled analysis of data. Catheter Cardio Inte 96: 1360-1366. https://doi.org/10.1002/ccd.28646 ![]() |
1. | Liqiong Jian, Xinyu Bai, Shaojuan Ma, Minyu Feng, Stochastic dynamical analysis for the complex infectious disease model driven by multisource noises, 2024, 19, 1932-6203, e0296183, 10.1371/journal.pone.0296183 | |
2. | Rujie Yang, Hong Qiu, A Valid Transport Related SVEIHR Stochastic Epidemic Model with Coverage and Time Delays, 2024, 23, 2224-2880, 815, 10.37394/23206.2024.23.84 | |
3. | Munkaila Dasumani, Sianou Ezéckiel Houénafa, Gohouede Lionel Cédric, Binandam S. Lassong, Stephen E. Moore, Deterministic and stochastic models for analyzing the dynamics of diabetes mellitus, 2025, 26668181, 101202, 10.1016/j.padiff.2025.101202 |